This approach improves classification accuracy of lung adenocarcinoma using gene expression data, indicating strong potential for biomarker discovery.
High dimensionality, redundant features, and poor cross-dataset generalization hinder Lung Adenocarcinoma (LUAD) classification using gene expression data. This study proposes Hybrid Statistical-Spectral Sparse Feature Selection with Optimization (HS3FS+), a novel framework that integrates Mutual Information (MI) and Kullback-Leibler (KL) divergence for feature ranking, Kernel Principal Component Analysis (KPCA) for nonlinear transformation, pathway-guided filtering for biological validation, and Genetic Algorithm (GA)-based optimization for feature selection. The framework was validated on four independent datasets: The Cancer Genome Atlas (TCGA)-LUAD, Gene Expression Omnibus (GEO) datasets GSE19188 and GSE37745, and TCGA-Lung Squamous Cell Carcinoma (TCGA-LUSC), ensuring robust cross-platform evaluation. HS3FS+ achieved classification accuracy of 98.3% on TCGA-LUAD, 97.1% on GSE19188, 96.0% on GSE37745, and 94.8% on TCGA-LUSC. The selected gene signatures exhibit strong concordance with established LUAD biomarkers, supporting both biological relevance and model interpretability. Additionally, the method demonstrated a fivefold reduction in computational time compared to Deep Learning (DL)–based feature selection approaches. These findings confirm HS3FS+ as a robust, interpretable, and scalable solution for LUAD classification, with potential applications in biomarker discovery and precision oncology.
No takes yet. Share an insight, caveat, or question.
Sara Haddou Bouazza (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: